Nexium I.V. 40mg Sol , 1vial

Esomeprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase (proton pump) in the gastric parietal cell. It is the S-isomer of omeprazole. By acting specifically on the proton pump, esomeprazole blocks the final step in acid production, thereby reducing gastric acidity regardless of the stimulus.

Urgent Side Effects: Seek Medical Help Right Away

Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Signs of electrolyte problems: mood changes, confusion, muscle pain, cramps, or spasms, weakness, shakiness, change in balance, abnormal heartbeat, seizures, loss of appetite, or severe upset stomach or vomiting.
Signs of kidney problems: inability to pass urine, change in urine output, blood in the urine, or significant weight gain.
Severe dizziness or fainting.
Bone pain.
Significant weight loss.
Irritation at the injection site.
Symptoms of C. diff-associated diarrhea (CDAD): stomach pain or cramps, very loose or watery stools, or bloody stools. Do not attempt to treat diarrhea without consulting your doctor.
Severe skin reactions, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions, which can be life-threatening. Seek medical help immediately if you experience: red, swollen, blistered, or peeling skin; red or irritated eyes; sores in your mouth, throat, nose, eyes, genitals, or skin; fever; chills; body aches; shortness of breath; or swollen glands.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. If you are bothered by any of the following side effects or if they do not go away, contact your doctor:

Headache.
Stomach pain or diarrhea.
Constipation.
Gas.
Dry mouth.
* Upset stomach.

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you are currently taking any of the following medications: Atazanavir, clopidogrel, methotrexate, nelfinavir, rifampin, rilpivirine, St. John's wort, or warfarin.
* If you have a history of certain health issues, including:
+ Black or bloody stools
+ Heartburn accompanied by lightheadedness, sweating, dizziness, or wheezing
+ Chest pain
+ Shoulder pain with shortness of breath
+ Pain that radiates to the arms, neck, or shoulders
+ Lightheadedness
+ Excessive sweating
+ Vomiting blood
+ Difficulty or pain when swallowing food

Please note that this is not an exhaustive list of all potential interactions. Therefore, it is crucial to discuss all your medications (including prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. This will help ensure your safety when taking this medication. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Adhere to the prescribed duration of treatment, as taking this drug for longer than recommended by your doctor may have adverse effects. Additionally, be aware that this medication may interfere with certain laboratory tests, so it is crucial to notify all your healthcare providers and laboratory personnel that you are taking this drug.

Patients with osteoporosis (weak bones) should be cautious, as this medication may increase the risk of fractures in the hip, spine, and wrist. This risk may be higher if you take high doses of this medication, use it for more than a year, or are over 50 years old. If you have risk factors for osteoporosis, such as a history of alcohol consumption, smoking, steroid use, seizure medication, or a family history of osteoporosis, discuss your risks with your doctor.

Prolonged use of this medication (typically more than three months) may lead to rare but potentially serious side effects. For instance, low magnesium levels may occur, often after one year of treatment, which can cause other electrolyte imbalances. Your doctor may recommend regular blood tests to monitor your magnesium levels. Furthermore, long-term treatment (usually more than three years) with this type of medication has been associated with low vitamin B-12 levels. Be aware of the symptoms of vitamin B-12 deficiency, including shortness of breath, dizziness, abnormal heartbeat, muscle weakness, pale skin, fatigue, mood changes, or numbness and tingling in the arms and legs, and seek medical attention immediately if you experience any of these symptoms.

In rare cases, this medication has been linked to the development or worsening of lupus. If you have a history of lupus, inform your doctor, and be vigilant for signs of the condition, such as a rash on the cheeks or other areas, changes in skin color, increased sensitivity to sunlight, muscle or joint pain, chest pain or shortness of breath, or swelling in the arms and legs. Seek medical attention promptly if you notice any of these symptoms.

Long-term use of this medication (more than one year) may also increase the risk of developing stomach growths called fundic gland polyps. If you have concerns or questions, discuss them with your doctor.

If you are pregnant, planning to become pregnant, or breastfeeding, it is essential to consult with your doctor to weigh the benefits and risks of this medication to both you and your baby.

• Nelfinavir
• Atazanavir

• Clopidogrel (reduced antiplatelet effect)
• Warfarin (increased INR)
• Methotrexate (increased methotrexate levels, especially high-dose)
• Digoxin (increased digoxin levels)
• Iron salts (reduced absorption)
• Ketoconazole (reduced absorption)
• Itraconazole (reduced absorption)
• Erlotinib (reduced absorption)

• Tacrolimus (increased tacrolimus levels)
• Cilostazol (increased cilostazol levels)
• Diazepam (reduced clearance of diazepam)
• Phenytoin (increased phenytoin levels)
• Voriconazole (increased esomeprazole exposure)
• St. John's Wort (decreased esomeprazole exposure)

• Not available (interactions are typically categorized as major/moderate due to clinical significance)

• Resolution of heartburn, regurgitation, dysphagia
• Signs of gastrointestinal bleeding (e.g., black, tarry stools; coffee-ground emesis)
• Symptoms of Clostridium difficile-associated diarrhea (CDAD) (e.g., persistent diarrhea, abdominal pain, fever)
• Symptoms of hypomagnesemia (e.g., muscle cramps, weakness, tremors, arrhythmias, seizures)
• Symptoms of acute interstitial nephritis (e.g., fever, rash, nausea, malaise, acute kidney injury)

Esomeprazole is Pregnancy Category B. Studies in animals have not shown harm to the fetus, but there are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if clearly needed and the potential benefit outweighs the potential risk to the fetus.

Esomeprazole is excreted in human milk. However, the amount is generally considered low, and adverse effects on the breastfed infant are not expected. Use with caution, and monitor the infant for any adverse effects (e.g., diarrhea, drowsiness).

Approved for the short-term treatment of GERD with erosive esophagitis in pediatric patients aged 1 month to 17 years. Dosing is weight-based for younger children. Safety and effectiveness in neonates (<1 month) have not been established.

No overall differences in safety or effectiveness have been observed between elderly and younger patients. No specific dose adjustment is required based on age alone. However, consider age-related decreases in renal, hepatic, or cardiac function, and concomitant disease or other drug therapy.

• Nexium I.V. is typically used for short-term treatment (7-10 days) in patients who cannot take oral PPIs, followed by transition to oral therapy.
• For Zollinger-Ellison Syndrome, the IV dose can be adjusted to maintain gastric acid output below 10 mEq/hour (or <1 mEq/hour in patients with prior partial gastrectomy).
• Long-term use of PPIs, including esomeprazole, has been associated with an increased risk of C. difficile infection, hypomagnesemia, bone fractures, and vitamin B12 deficiency.
• Acute interstitial nephritis has been observed in patients taking PPIs, including esomeprazole, and can occur at any point during therapy.
• PPIs may interfere with the antiplatelet effect of clopidogrel; consider alternative antiplatelet therapy or acid suppression if clinically appropriate.
• Administer IV infusion over 10-30 minutes for intermittent dosing, or as a continuous infusion for specific indications (e.g., ulcer rebleeding).

• Other intravenous Proton Pump Inhibitors (e.g., Pantoprazole IV, Omeprazole IV)
• H2-receptor antagonists (e.g., Famotidine IV, Ranitidine IV - if available)
• Antacids (for symptomatic relief, not for healing)

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further guidance. To ensure your safety and the safety of others, never share your prescription medications with anyone, and do not take medications that have been prescribed to someone else.

All medications should be stored in a secure location, out of the reach of children and pets, to prevent accidental ingestion. When disposing of unused or expired medications, do not flush them down the toilet or pour them down the drain unless specifically instructed to do so by a healthcare professional or pharmacist. Instead, consult with your pharmacist to determine the best method for disposal, as some communities may have designated drug take-back programs.

Additionally, some medications may come with a separate patient information leaflet; if you have questions or concerns, your pharmacist can provide more information. If you have any questions or concerns about your medication, it is crucial to discuss them with your doctor, nurse, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide detailed information about the medication, including the amount taken, the time it was taken, and any other relevant details.